Wednesday, May 03, 2023 7:46:37 PM
The shares have been sold.
About 2 dozen folks own about 90% and certain projects are funded. We’re good with the risk.
Either it pays off or it doesn’t. EXPL could always access the market at a later date, but that’s doubtful. Sorry bro!
Here’s our CEO in a documentary about changes in the industry in recent years. For those that understand the industry it might make sense as to why the OTC wouldn’t be attractive.
It’s like the old saying, when one door closes it opens up other doors.
WARNING: It’s for those that understand the industry changes. Those that don’t will think the OTC is the way to prosperity or something won’t understand, but that’s okay.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM